The Latest Breaking News from Vaccine

There has been an outbreak of monkeypox cases in a number of countries that are not endemic for the virus. Monkeypox is caused by an orthopoxvirus that is closely related to the virus that caused smallpox. Monkeypox is an animal virus that occasionally infects humans after they are bitten or…

Pfizer says it will provide nearly two dozen products, including its top-selling COVID-19 vaccine and treatment, at not-for-profit prices in some of the world’s poorest countries

Pfizer says it will provide nearly two dozen products at not-for-profit prices in some of the world’s poorest countries

The Shire of York will write to WA Premier Mark McGowan on behalf of its ratepayers, who are demanding an end to Covid-19 vaccine mandates.

From Monday about 1.5 million aged 16-64 qualify for fourth dose after updated advice that excludes people without serious risk factors

An extra 1.5 million people are now eligible to receive a fourth COVID-19 vaccine, or second booster.

The nation's vaccine advisory group recommends another 1.5 million Australians get a fourth COVID-19 booster shot coming into the winter months.

So far this year, the Northern Territory has recorded 968 cases of influenza, compared to just 76 cases in all of 2021.

SVB Leerink is initiating coverage of HilleVax Inc (NASDAQ:HLVX) shares with an Outperform rating and a $30 price target.  The analyst believes the company’s potentially first-in-class infant norovirus vaccine HIL214 represents a uniquely de-risked opportunity.  It estimates $625 million in risk-adjusted infant HIL214 sales in 2030E ($1 billion unadjusted).  The outlook is supported by…